INO Financial Facts

Grant and miscellaneous revenue: 6.18M
License fee and milestone revenue: 1.8M
See Full Income Statement

Deferred tax liabilities: 175.64K
Total current liabilities: 33.4M
See Full Balance Sheet

Inovio Pharma (INO) Earnings

  |   Expand Research on INO
Next EPS Date 8/10/16 *Est. EPS Growth Rate +35.3% *Last Qtr.
Average EPS % Beat Rate -6.8% Revenue Growth Rate +55.8% *Last Qtr.
Average % Move 1-Wk after EPS +5.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/9/16 Q116 -$0.11-$0.14 +$0.03$8.1M$4.75M N/A Details
3/14/16 Q415 -$0.25-$0.20 -$0.05$5.94M$6.96M N/A Details
11/9/15 Q315 $0.07N/A N/A $24.18M$1.84M N/A Details
8/10/15 Q215 -$0.09-$0.13 +$0.04$5.3M$5.52M N/A Details
5/11/15 Q115 -$0.17-$0.11 -$0.06$5.2M$7.04M N/A Details
3/16/15 Q414 -$0.12-$0.10 -$0.02$2.5M$5.24M N/A Details
11/10/14 Q314 -$0.12-$0.14 +$0.02$1.8M$5.6M N/A Details
8/11/14 Q214 -$0.18-$0.19 +$0.01$3.8M$1.8M N/A Details